Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to -$285.9 million.

  • Collegium Pharmaceutical's Enterprise Value fell 13830.46% to -$285.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$285.9 million, marking a year-over-year decrease of 13830.46%. This contributed to the annual value of -$162.8 million for FY2024, which is 4758.85% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Enterprise Value of -$285.9 million as of Q3 2025, which was down 13830.46% from -$222.2 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Enterprise Value's 5-year high stood at -$106.7 million during Q1 2022, with a 5-year trough of -$325.5 million in Q2 2023.
  • Over the past 5 years, Collegium Pharmaceutical's median Enterprise Value value was -$197.8 million (recorded in 2025), while the average stood at -$215.3 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 16520.92% in 2023, then surged by 6061.37% in 2024.
  • Collegium Pharmaceutical's Enterprise Value (Quarter) stood at -$186.4 million in 2021, then rose by 6.83% to -$173.7 million in 2022, then crashed by 78.8% to -$310.5 million in 2023, then soared by 47.59% to -$162.8 million in 2024, then plummeted by 75.63% to -$285.9 million in 2025.
  • Its last three reported values are -$285.9 million in Q3 2025, -$222.2 million for Q2 2025, and -$197.8 million during Q1 2025.